10-Q: Bowen Acquisition Corp Faces Deepening Financial Distress and Nasdaq Non-Compliance Amidst Stalled Merger

Bowen Acquisition Corp reported a substantial net loss of over $2 million for the first quarter of 2025, primarily driven by costs associated with its pending business combination and a significant reduction in its trust account due to shareholder redemptions, while also facing a Nasdaq non-compliance notice for a delayed filing.

Summary

• Reported a net loss of $2,039,997 for the three months ended March 31, 2025, a significant decline from a net income of $786,362 in the same period of 2024.
• Cash and cash equivalents decreased to $29,806 as of March 31, 2025, from $103,774 at December 31, 2024.
• The investment held in the Trust Account significantly reduced to $9,372,109 as of March 31, 2025, from $75,794,241 at December 31, 2024, primarily due to substantial shareholder redemptions.
• Incurred a loss of $1,929,656 on the initial issuance of a Forward Purchase Agreement (FPA) liability.
• Recognized a gain of $367,317 from the change in fair value of the FPA liability.
• Financing expenses amounted to $336,000 related to the FPA.
• Shareholder redemptions in connection with extension votes and business combination approval reduced public shares from 6,900,000 at December 31, 2024, to 847,905 at March 31, 2025, and further to 744,473 by April 14, 2025.
• The company has a working capital deficit of $2,600,374 as of March 31, 2025.
• Received a Nasdaq notice on May 28, 2025, for failing to file its Quarterly Report on Form 10-Q for the quarter ended March 31, 2025, by the due date.

Sentiment

Score: 2

Explanation: The company reported a substantial net loss, experienced massive shareholder redemptions leading to a depleted trust account, and faces a going concern warning. Additionally, it received a Nasdaq non-compliance notice for a delayed filing and identified a material weakness in internal controls, all of which indicate severe operational and financial distress.

Positives

• Shareholders approved the business combination with Qianzhi on January 14, 2025.
• The Registration Statement on Form S-4 for the business combination was declared effective on December 18, 2024.
• Qianzhi, the target company, agreed to be responsible for all expenses incurred by the Company in connection with the business combination, with $255,513 reimbursed for the three months ended March 31, 2025.
• Recognized a gain of $367,317 from the change in fair value of the FPA liability.

Negatives

• Reported a net loss of $2,039,997 for the three months ended March 31, 2025, compared to a net income of $786,362 for the same period in 2024.
• Significant decrease in cash and cash equivalents to $29,806 as of March 31, 2025.
• The Trust Account balance drastically reduced from $75,794,241 at December 31, 2024, to $9,372,109 at March 31, 2025, due to high redemptions.
• Incurred a substantial loss of $1,929,656 on the initial issuance of the FPA liability.
• Has a working capital deficit of $2,600,374 as of March 31, 2025.
• Received a Nasdaq non-compliance notice on May 28, 2025, for failing to file its 10-Q report for Q1 2025.
• Interest earned on investments held in the trust account significantly decreased to $97,321 for the three months ended March 31, 2025, from $923,492 in the prior year period.

Risks

• Substantial doubt about the ability to continue as a going concern due to a working capital deficit of $2,600,374 and the uncertainty of completing a Business Combination within the Combination Period.
• Risk of liquidation and dissolution if the Business Combination is not completed within the extended Combination Period.
• Inability to regain compliance with Nasdaq listing requirements regarding timely filing of reports, potentially leading to delisting.
• Material weakness in internal control over financial reporting due to a lack of qualified SEC reporting professionals.
• Reliance on additional funds from related parties to provide necessary working capital.
• The FPA liability is a Level 3 financial instrument, indicating reliance on unobservable inputs for fair value measurement, which can introduce volatility and uncertainty.
• Holders of rights will not receive any funds for their rights and the rights will expire worthless if the company is unable to complete the initial Business Combination within the required time period and redeems public shares.

Future Outlook

The company expects to continue incurring significant professional and transaction costs in pursuit of its business combination. Management anticipates obtaining additional funds from related parties to provide the necessary working capital to consummate the business combination. The business combination with Qianzhi remains pending, awaiting required regulatory approvals. The company is also working diligently to complete its delinquent Quarterly Report on Form 10-Q and intends to submit a plan to Nasdaq to regain compliance by July 28, 2025.

Management Comments

• Management believes that these conditions raise substantial doubt about the Company's ability to continue as a going concern.
• Management expects to obtain additional funds from related parties to provide the additional working capital necessary to carry out its objective to consummate a business combination.
• Management intends to continue implement remediation steps to improve our disclosure controls and procedures and our internal control over financial reporting.
• We have improved this process by enhancing access to accounting literature, identification of third-party professionals with whom to consult regarding complex accounting applications and consideration of additional staff with the requisite experience and training to supplement existing accounting professionals.

Industry Context

This filing reflects the inherent challenges and risks associated with Special Purpose Acquisition Companies (SPACs), particularly the high rate of shareholder redemptions that can significantly deplete the trust account, making it difficult to complete a business combination. The need for multiple extensions and the substantial reduction in cash highlight the increasing difficulty for SPACs to find and close suitable deals in the current market environment, often leading to liquidation or highly diluted post-merger entities. The reliance on related party funding and the ongoing regulatory hurdles are common themes in the SPAC lifecycle, especially as deadlines approach.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• Promissory Note: EarlyBirdCapital, Inc. loaned $500,000 to the Company on October 14, 2024, for the extension, repayable upon business combination.
• Founder Shares Transfer: One of the Sponsors transferred 30,000 Founder Shares to EarlyBirdCapital, Inc. (valued at $209,442) in connection with the $500,000 loan.
• Due to Related Party: $136,613 owed as of March 31, 2025, including $120,000 for administration fees and $16,613 for accounting and other service fees.
• Accounting Service Agreement: TenX Global Capital (related party) provides accounting services at a fixed quarterly rate of $5,250.
• Administration Fee: An affiliate of the Sponsors charges up to $10,000 per month for office, utilities, and personnel.
• Business Combination Transaction Cost: Qianzhi agreed to be responsible for all business combination expenses incurred by the Company, with $255,513 reimbursed for the three months ended March 31, 2025.

Stakeholder Impact

• Shareholders: Significant dilution of trust account value due to high redemptions. Uncertainty regarding the completion of the business combination and the company's ability to continue as a going concern poses a substantial risk to remaining shareholders. Holders of rights will lose their value if the business combination is not completed.
• Creditors: Promissory notes from related parties are repayable upon business combination, but the going concern risk introduces uncertainty.
• Management/Employees: Continued operational challenges and the need to secure additional funding from related parties. The identified material weakness in internal controls indicates a need for improved financial reporting capabilities.
• Target Company (Qianzhi): The business combination is pending regulatory approvals, and the significant reduction in Bowen's trust account and going concern issues could impact the final deal structure or its viability.

Next Steps

• Complete the business combination with Shenzhen Qianzhi BioTechnology Co. Ltd., pending required regulatory approvals.
• Obtain additional funds from related parties to address working capital deficiencies.
• Submit a plan to Nasdaq by July 28, 2025, to regain compliance for the delinquent Quarterly Report on Form 10-Q.
• Implement remediation steps to improve disclosure controls and procedures and internal control over financial reporting, including enhancing access to accounting literature, consulting third-party professionals, and considering additional staff.

Key Dates

Recommendation

Keywords

SPAC, Special Purpose Acquisition Company, Bowen Acquisition Corp, BOWN, Qianzhi, Shenzhen Qianzhi BioTechnology Co. Ltd., Business Combination, Merger, 10-Q, Quarterly Report, SEC Filing, Financial Results, Trust Account, Shareholder Redemptions, Going Concern, Nasdaq Non-Compliance, Forward Purchase Agreement, FPA Liability, Internal Controls, Financial Deficit